MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

Search

Accuray Inc

Cerrado

SectorSalud

1.6 -5.33

Resumen

Variación precio

24h

Actual

Mínimo

1.5899999999999999

Máximo

1.6800000000000002

Métricas clave

By Trading Economics

Ingresos

2.4M

1.1M

Ventas

14M

128M

Margen de beneficio

0.88

Empleados

990

EBITDA

9.4M

10M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+255.03% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

50M

190M

Apertura anterior

6.93

Cierre anterior

1.6

Noticias sobre sentimiento de mercado

By Acuity

13%

87%

13 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Accuray Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

21 oct 2025, 23:55 UTC

Acciones populares

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 oct 2025, 23:49 UTC

Ganancias

Texas Instruments Warns of Slower Semiconductor Industry Recovery -- Update

21 oct 2025, 21:40 UTC

Ganancias

Waste Connections 3Q Revenue Rises

21 oct 2025, 21:14 UTC

Ganancias
Principales Movimientos del Mercado

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 oct 2025, 21:05 UTC

Adquisiciones, fusiones, absorciones

GE Vernova to Acquire Full Stake in Prolec GE Joint Venture

21 oct 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

DraftKings to Launch Prediction Markets Platform

21 oct 2025, 20:38 UTC

Ganancias

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

21 oct 2025, 20:35 UTC

Ganancias

Capital One 3Q Sales, Profit Jump

21 oct 2025, 20:32 UTC

Ganancias

Texas Instruments 3Q Revenue Up on Growth Across End Markets

21 oct 2025, 23:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 oct 2025, 23:44 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen, Hopes for Takaichi's Econ Steps -- Market Talk

21 oct 2025, 23:39 UTC

Charlas de Mercado

Gold Consolidates; May Undergo Further Technical Correction -- Market Talk

21 oct 2025, 23:36 UTC

Charlas de Mercado

BHP Has Hidden Leverage to Gold's Rush -- Market Talk

21 oct 2025, 22:55 UTC

Adquisiciones, fusiones, absorciones

Scentre Says This Forms Part of Capital Management Strategy

21 oct 2025, 22:55 UTC

Adquisiciones, fusiones, absorciones

Scentre: Continues to Evaluate Strategic Opportunities Including New JV Partners

21 oct 2025, 22:54 UTC

Adquisiciones, fusiones, absorciones

Scentre Notes Media Report on Possible Sale of Stake in Westfield Chermside to Dexus Fund

21 oct 2025, 21:09 UTC

Charlas de Mercado
Ganancias

Netflix Creators Have Started Using AI in Production -- Market Talk

21 oct 2025, 20:58 UTC

Charlas de Mercado
Ganancias

Netflix Aims to Build on 'KPop Demon Hunters' Mania -- Market Talk

21 oct 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

21 oct 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

21 oct 2025, 20:43 UTC

Ganancias

Netflix Stock Drops After Earnings Miss Estimates -- Barrons.com

21 oct 2025, 20:41 UTC

Ganancias

Dow Industrials Hit Record, Boosted by Strong Earnings -- WSJ

21 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

GE Vernova: Deal Accelerates Growth for Electrification Segment >GEV

21 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

GE Vernova Acquiring Remaining 50% Stake of JV From Xignux >GEV

21 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

GE Vernova: Prolec GE Expects Low Double-Digit Rev Growth in Coming Years >GEV

21 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

GE Vernova: Prolec GE Expects $3B in Rev at 25% Adj EBITDA Margin in 2025 >GEV

21 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

GE Vernova: $5.275B Purchase Price at Closing, Expected to Be Funded Equally With Cash & Debt >GEV

21 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

GE Vernova Will Acquire Remaining 50% Stake of Prolec GE >GEV

21 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

GE Vernova To Fully Acquire Prolec GE Joint Venture >GEV

21 oct 2025, 20:29 UTC

Ganancias

Northrop Stock Tumbles on Sales Disappointment. When Good Isn't Good Enough. -- Barrons.com

Comparación entre iguales

Cambio de precio

Accuray Inc Esperado

Precio Objetivo

By TipRanks

255.03% repunte

Estimación a 12 meses

Media 6 USD  255.03%

Máximo 7 USD

Mínimo 5 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Accuray Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

1.28 / 1.61Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

13 / 371 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat